References
- Dighiero G, Maloum K, Desablens B et al. Chlorambucil in indolent chronic lymphocytic leukemia: French Cooperative group on Chronic Lymphocytic leukemia. N Eng J Med 1998; 338: 1506–1514.
- Rai KR, Sawitzky A, Cronkite EP et al. Clinical staging of chroniclymphocytic leukemia. Blood 1975; 46: 219–234.
- Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206.
- Binet JL, Caligaris-Cappio F, Catovsky D et al. Perspectives on theuse of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006; 107: 859–861.
- Byrd JC, Stilgenbauer S, Flinn IW. ASH Education Program book Washington DC: American Society of Hematology; 2004: 163–183.
- Deaglio S, Vaisitti T, Bergui L et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 2005; 105: 3042–3050.
- Byrd JC. A new twist for CD38 antigen expression in CLL. Blood2005; 105: 3002.
- Cheson BD, Bennett JM, Greyer M et al. National Cancer Institute—sponsored working group guidelines for chronic lym-phocytic leukemia. Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997.
- Krober A, Seiler TI, Benner A et al. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416.
- Thornton PD, Fernandez C, Giustolisi GM et al. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol J 2004; 5: 145–151.
- Kaplan E, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
- Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J Roy Stat Soc A 1972; 135: 185–206.
- Cox DR. Regresion models and life tables. J Roy Stat Soc B 1972; 34: 187–220.
- Ibrahim Sh, Keating M, Do Kim-Anh et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukae-mia. Blood 2001; 98: 181–186.
- Gentile M, Mauro FR, Calabrese E et al. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol 2005; 130: 549–557.
- Hamblin Ti, Orchard JA, Ibbotson RE et al. CD38 expression and inmunoglobulin variable region mutations are independent prog-nostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during course of the disease. Blood 2002; 99: 1023–1029.
- Damle RN, Wasil T, Fais F et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
- Del Poeta G, Maurillo L, Vendetti A et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001; 98: 2633–2639.